Horizon Health Pharma
About
Advancing Cannabinoid Science & Pharmaceutical Excellence
Horizon Health Pharma stands at the intersection of science, compliance, and innovation, providing a fully integrated platform for the advancement of cannabinoid-based medicine worldwide.
At Horizon Health Pharma, we specialize in the sourcing, conversion, and formulation of medical-grade cannabis and cannabinoid APIs for the European and global pharmaceutical markets.
Services
Medical Cannabis Supply
Direct B2B distribution of high-grade GACP - certified cannabis, both and above and below 27% THC, exclusively to GDP-licensed companies.
Our global cultivation network spans over 85 licensed facilities under exclusive European supply agreements, ensuring consistency, traceability, and full pharmaceutical compliance.
Cannabinoid Raw Materials
Supply of pharma-grade isolated and distilled cannabinoid materials, including THC, CBD, CBG, CBN, and other minor cannabinoids, compliant with GMP and pharmacopoeia standards, suitable for formulation and clinical research applications.
Regulatory & Compliance Consulting
Expert advisory on EU-wide import/export compliance, narcotic licensing frameworks, and international regulatory pathways for controlled and non-controlled cannabinoid derivatives
EU-GMP Conversion
Comprehensive GMP-1 and GMP-2 processing through certified European partners, including facilities in the Czech Republic, offering end-to-end technical, analytical, and regulatory support provided by our highly qualified pharmaceutical team
Contact
For any inquiries and information